IMRIS reports shareholder vote results at annual meeting - FOX 42: Omaha News, Sports and Weather; |

IMRIS reports shareholder vote results at annual meeting

Information contained on this page is provided by an independent third-party content provider. WorldNow and this Station make no warranties or representations in connection therewith. If you have any questions or comments about this page please contact


WINNIPEG, May 14, 2014 /PRNewswire/ - IMRIS Inc. (NASDAQ: IMRS; TSX: IM) has announced results of the shareholder vote at its 2014 annual general meeting held May 13, 2014 in Toronto.  The Company reported that a substantial majority of the shareholders approved the following management proposals:

  • Director nominees H. David Graves, Stephen Armstrong, Carey Diamond, William Fraser, James Hickey, Blaine Hobson, and Jay D. Miller were each re-elected to IMRIS' Board of Directors. Each director received at least 98.62 percent of the vote cast "For."

  • The re-appointment of Deloitte and Touche LLP as auditors of the company, with approximately 95.78 percent of the votes cast "For."

There were no shareholder proposals put forth.

IMRIS (NASDAQ: IMRS; TSX: IM) is a global leader in providing image guided therapy solutions through its VISIUS Surgical Theatre - a revolutionary, multifunctional surgical environment that provides unmatched intraoperative vision to clinicians to assist in decision making and enhance precision in treatment. The multi-room suites incorporate diagnostic quality high-field MR, CT and angio modalities accessed effortlessly in the operating room setting. VISIUS Surgical Theatres serve the neurosurgical, cardiovascular, spinal and cerebrovascular markets and have been selected by 57 leading medical institutions around the world. For more information, visit

©2012 PR Newswire. All Rights Reserved.

Powered by WorldNow

General Information:

Phone: 402-554-4282
Fax: 402-554-4279

Can't find something?
Powered by WorldNow
All content © Copyright 2000 - 2014 WorldNow and KPTM. All Rights Reserved.
For more information on this site, please read our Privacy Policy and Terms of Service.